India pharma companies develop versions of Wegovy to get in on weight-loss windfall

With some analysts predicting a weight-loss market reaching $100 billion a year or more by the end of the decade, executives at Sun Pharma, Cipla, Dr Reddy#39;s and Lupin -- some of the world#39;s largest generic drugmakers -- all said they have started work on Wegovy versions. Read The Rest at :